Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001087294-25-000008
Filing Date
2025-10-03
Accepted
2025-10-03 16:02:16
Documents
1
Period of Report
2025-09-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1759521732.html 4  
1 FORM 4 wk-form4_1759521732.xml 4 33569
  Complete submission text file 0001087294-25-000008.txt   35041
Mailing Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE TN 37203
Business Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 621765329 | State of Incorp.: TN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1600 WEST END AVE., SUITE 1300 SUITE 1300 NASHVILLE TN 37203
Business Address
Jones James (Reporting) CIK: 0001490829 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 251373661